Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

Latest news

  • January 25, 2010

    Theratechnologies reports that the FDA will reschedule for administrative reasons the Advisory Committee meeting to review tesamorelin’s NDA More...

  • January 18, 2010

    Theratechnologies reports date for FDA Advisory Committee Review of the Tesamorelin New Drug Application More...


Events

  • From January 12 to 13, 2010

    Biotech Showcase 2010, San Francisco, USA

    Presentation by Yves Rosconi, President and Chief Executive Officer

    Conference: Biotech Showcase 2010
    Date: January 12, 2010
    Time: 3:20 p.m. (Pacific Time)
    Place: Marine's Memorial Club &Hotel San Francisco

    More...

 

Stock information

Symbol TSX : TH
Last trade 4.74
Open 4.85
Net change -0.05
High 4.85
Low 4.62
52 week range 0.00 - 0.00
Volume 70,875
As of 2010-02-08
15:58 EST
Note: Quotes are delayed.
For informational purposes only.